Lexicon Pharmaceuticals | LXRX - Varlıklar





Varlıklar Değişiklik Tarih
Abbott USD 110.43B 23.72B 2026-03
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics USD 349.66M 12.86M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
BioMarin Pharmaceutical USD 11.72B 3.13B 2026-06
Coherus Biosciences USD 191.18M 74.84M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Illumina USD 6.65B 91M 2026-06
Insmed USD 2.1B 26.7M 2026-06
Ironwood Pharmaceuticals USD 434.57M 37.66M 2026-03
J&J USD 201.06B 167M 2026-06
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 345.41M 127.54M 2026-06
MannKind USD 732.3M 12.1M 2026-06
Merck USD 129.8B 1.12B 2026-06
Moderna USD 10.96B 527M 2026-06
Novartis USD 122.03B 3.5B 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
United Therapeutics USD 7.22B 505.9M 2026-06
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12